Lancer Containers Lines Ltd

Lancer Containe. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Lancer Containers Lines Ltd

₹ 71.8 0.41%
16 Apr - close price
lancermarine.in BSE: 539841
About

Incorporate in 2011, Lancer Container Lines Ltd is in the business of shipping and logistics services in India and abroad

Key Points

Business Overview
The company's primary business is Ocean transport services of intermodal containers by container ships (NVOCC – Non-Vessel Operating Common Carrier). [1] It operates an asset-light business with a mix of 14,000+ owned and leased containers, offering services to 86 ports as well as inland destinations through 14 offices in India and a subsidiary in Dubai, covering more than 30 countries. [2]

Website BSE
  • Market Cap ₹ 1,642 Cr.
  • Current Price ₹ 71.8
  • High / Low ₹ 110 / 40.3
  • Stock P/E 60.6
  • Book Value ₹ 12.8
  • Dividend Yield 0.00 %
  • ROCE 23.7 %
  • ROE 33.8 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 42.7% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 35.3%
  • Company's median sales growth is 37.4% of last 10 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -1.11%
  • Debtor days have increased from 36.3 to 43.9 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Logistics Industry: Miscellaneous

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
64.81 111.41 101.15 121.79 154.69 217.68 205.30 195.70 136.07 144.63 108.54 112.34 104.83
58.59 105.86 95.31 112.11 141.16 199.57 186.33 175.28 118.37 130.58 93.43 99.19 92.74
Operating Profit 6.22 5.55 5.84 9.68 13.53 18.11 18.97 20.42 17.70 14.05 15.11 13.15 12.09
OPM % 9.60% 4.98% 5.77% 7.95% 8.75% 8.32% 9.24% 10.43% 13.01% 9.71% 13.92% 11.71% 11.53%
0.21 0.82 0.52 0.24 0.29 0.98 1.60 1.92 1.95 5.61 2.18 4.68 3.57
Interest 0.84 0.84 0.72 0.54 0.52 0.61 1.52 2.85 3.92 4.00 3.79 3.34 2.46
Depreciation 2.34 3.00 2.18 2.26 2.25 2.81 3.07 3.84 4.37 4.53 4.03 4.25 4.27
Profit before tax 3.25 2.53 3.46 7.12 11.05 15.67 15.98 15.65 11.36 11.13 9.47 10.24 8.93
Tax % 28.62% 20.95% 26.88% 24.44% 27.51% 28.65% 25.78% 21.98% 20.42% 38.27% 25.34% 31.15% 31.69%
2.33 2.00 2.54 5.38 8.01 11.19 11.86 12.22 9.03 6.87 7.07 7.06 6.11
EPS in Rs 0.13 0.11 0.14 0.30 0.44 0.62 0.66 0.68 0.50 0.37 0.38 0.33 0.27
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
5 21 22 30 43 78 109 197 265 300 595 682 470
5 20 20 27 37 71 95 177 243 276 548 610 416
Operating Profit 0 0 2 4 6 6 14 21 22 23 47 71 54
OPM % 1% 2% 8% 13% 15% 8% 13% 10% 8% 8% 8% 10% 12%
0 0 0 0 -0 2 1 1 1 1 2 11 16
Interest 0 0 1 1 2 2 2 2 3 3 3 12 14
Depreciation 0 0 1 2 4 4 5 7 9 10 10 16 17
Profit before tax 0 0 1 1 1 2 9 12 11 12 37 54 40
Tax % 50% 32% 31% 31% 28% 19% 26% 30% 26% 26% 27% 26%
0 0 0 0 1 2 7 8 8 9 27 40 27
EPS in Rs 1.16 0.05 0.05 0.10 0.38 0.46 0.44 0.49 1.50 2.17 1.35
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 6% 0% 0%
Compounded Sales Growth
10 Years: 42%
5 Years: 44%
3 Years: 37%
TTM: -38%
Compounded Profit Growth
10 Years: 73%
5 Years: 43%
3 Years: 71%
TTM: -39%
Stock Price CAGR
10 Years: %
5 Years: 77%
3 Years: 165%
1 Year: 37%
Return on Equity
10 Years: 34%
5 Years: 34%
3 Years: 35%
Last Year: 34%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0 0 1 3 4 6 10 10 10 10 30 31 108
Reserves 0 1 1 1 2 5 9 17 25 34 40 135 185
2 3 8 14 20 21 20 35 30 31 42 283 162
1 5 7 5 8 9 13 22 31 45 80 36 22
Total Liabilities 4 8 17 23 34 41 52 84 96 120 192 484 477
2 4 7 18 26 28 35 63 66 65 81 109 113
CWIP 0 0 0 0 0 0 3 0 0 0 5 0 0
Investments 0 0 0 0 0 0 1 2 3 4 3 6 4
2 4 10 5 8 13 14 18 27 51 104 370 359
Total Assets 4 8 17 23 34 41 52 84 96 120 192 484 477

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-1 2 -1 8 6 6 15 21 17 29 51 -13
-2 -2 -4 -13 -12 -6 -15 -34 -6 -4 -18 -38
3 0 5 6 7 2 -0 12 -9 -13 -6 36
Net Cash Flow 0 -0 0 1 1 2 0 -1 2 12 28 -15

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 56 47 62 25 21 29 25 21 25 35 30 44
Inventory Days 46 50 355 0
Days Payable 14 203 422
Cash Conversion Cycle 88 -106 -4 25 21 29 25 21 25 35 30 44
Working Capital Days 36 -12 13 -45 -44 -25 -13 -15 -8 -14 -15 27
ROCE % 10% 17% 13% 13% 13% 30% 28% 22% 22% 43% 24%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.44% 74.44% 71.14% 70.72% 64.01% 55.05% 55.05% 53.92% 53.92% 52.56% 44.69% 43.56%
0.00% 0.56% 4.31% 6.63% 13.60% 20.46% 19.96% 19.13% 17.49% 11.46% 23.31% 20.80%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.22% 2.79%
25.56% 25.00% 24.55% 22.65% 22.39% 24.48% 24.99% 26.95% 28.59% 35.81% 31.78% 32.86%
No. of Shareholders 2,6874,7216,7396,9177,18511,67226,74328,23230,10546,25645,05250,544

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls